Open AccessGLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia
Author(s) -
María J. Redondo,
Fida Bacha
Publication year - 2020
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/clinem/dgaa314
Subject(s) - agonist , type 2 diabetes , medicine , beta (programming language) , glucagon like peptide 1 receptor , diabetes mellitus , adjuvant therapy , receptor , endocrinology , adjuvant , chemotherapy , computer science , programming language
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom